Describe three steps in the second messenger system (i.e., cell signaling process) after norepinephrine binds to the receptor in an excitatory adrenergic synapse including at least one potential effect on the cell.

Changes in intracellular Ca2+ is one of the main governing factors that determines the direction of plasticity (i.e., whether a synapse potentiates or depresses). Provide a general mechanism to explain how changes in intracellular Ca2+ can result in either synaptic depression or synaptic potentiation (refer to our discussion on kinases and phosphatases).

Describe the biochemical signaling steps by which activation of the NMDA receptor causes the postsynaptic cell to fire larger EPSPs.

Describe the neurotransmitters shown in Section 11.14 in the selected neurotransmitters table. Give examples of how they might occur in the body.

Explain the Crosstalk between 2nd messenger systems and the purpose of each step of the pathway.

Arrange following the boxed information in sequence regarding the dissociation and reassociation of G proteins following the activation of a G protein coupled receptor. GTP-bound Ga, dissociates from B and y cuhunits Gas exchanges GTP for GDP Gas reassociates with By subunits and the rorentor reforms Binding of the ligand to a G-protein rounled recentor GTP-bound Gas binds and activates adenvlul rurlase GTP is hydrolyzed and GDP bound Gas suhunit dissoriates Conformational change Increased synthesis of CAMP from ATP

In schizophrenia, the neurons affected by dopamine are overstimulated. This condition is treated with drugs like chlorpromazine (Thorazine), which bind to the affected receptors and inhibit the dopamine signal. Does chlorpromazineact as an agonist or antagonist?

Explain the role, using diagrams wherever possible, of G protein coupled receptors mediating the following physiological effects. a. Positive inotropic and positive chronotropic effects in the heart b. Vasoconstriction in vascular smooth muscle cells.

Serotonin, norepinephrine, and dopamine are a group of neurotransmitters collectively called monoamines. A lack of these monoamines has been linked to depression. Depression is treated with dru that prolong the effect of these neurotransmitters either by preventing the re-uptake of the neurotransmitters, or by inhibiting the enzyme that breaks down these neurotransmitters. Which of the following statements about neurotransmitters'are true? The table lists the classifications of three antidepressants. Antidepressant Classification fluoxetine selective serotonin re-uptake inhibitor (SSRI) phenelzine monoamine oxidase (MAO) inhibitor amitriptyline tricyclic antidepressant Check all that apply. View Available Hint(s) MAO inhibitors are examples of monoamine antagonists. EFluoxetine inhibits the enzyme that breaks down monoamines. ODopamine plays a role in feelings of pleasure and pain. DA deficiency of serotonin norepinephrine, and dopamine is associated with depression. Some drug…

What is the structue of dopamin, and suggest the binding interactions of dopamine with the receptor. Draw a suggested model for the required interactions for agonistic and antagonistic activty in dopamine receptor.